Sector Watch: Healthcare - May 02 2018
This is an archive page. To See the most recent Healthcare Sectorwatch click here
IBB: $102.68 -1.37 -1.32% | XBI: $87.45 -0.46 -0.52% | Updated May 02, 2018 04:26 PM
| HEALTHCARE STOCKS - TOP GAINERS | ||||
|---|---|---|---|---|
| CYH Community Health Systems $592.1M |
5.09+1.12 13.3 M 7.0x |
28% | ||
| TRVN Trevena $138.6M |
2.07+0.26 3.0 M 4.6x |
14% | ||
| OCX OncoCyte $74.0M |
2.35+0.25 36.2 K |
12% | ||
| CASI52WH CASI Pharmaceuticals $518.6M |
7.97+0.83 1.6 M |
12% | ||
| ARCT Arcturus Therapeutics $59.5M |
5.56+0.56 21.8 K |
11% | ||
| HEALTHCARE STOCKS - TOP LOSERS | ||||
|---|---|---|---|---|
| ESPR Esperion Therapeutics $1.2B |
45.75-24.75 14.6 M 28.3x |
-35% | ||
| CSU52WL Capital Senior Living $292.8M |
9.53-2.19 2.2 M 6.1x |
-19% | ||
| AKRX52WL Akorn $1.6B |
12.55-2.21 11.6 M 4.6x |
-15% | ||
| SPNE SeaSpine Holdings $149.3M |
10.27-1.11 22.9 K |
-10% | ||
| NUVA NuVasive $2.5B |
48.15-4.99 3.0 M 4.2x |
-9% | ||
Not for trading - Data delayed up to 20 minutes from last update time.
Excludes companies with market caps below $50M.
Market Caps next to company names. Trading volumes below stock prices.
NNx - unusual volume NN times the 3-month avg. volume
52WL - 52-week Low in this trading session
52WH - 52-week High in this trading session
Healthcare Stocks Related News
AgeX Announces NIH Grant Award | Business Wire [businesswire.com]Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports First Quarter 2018 Financial Results [globenewswire.com]
FINAL DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Akorn, Inc. (Nasdaq: AKRX) To Contact The Firm [globenewswire.com]
Arcturus Therapeutics Founder Joseph Payne Successfully Prevents Board?s Egregious Attempt to Dilute Shareholders [globenewswire.com]
Esperion Announces Positive Top-Line Results from Pivotal Phase 3 Long-Term Safety Study of Bempedoic Acid [globenewswire.com]
Community Health Systems Announces Proposed Exchange Offers | Business Wire [businesswire.com]
Community Health Systems, Inc. Announces First Quarter 2018 Results with Net Operating Revenues of $3.689 Billion | Business Wire [businesswire.com]
Capital Senior Living Corporation Reports First Quarter 2018 Results [globenewswire.com]
Rosen Law Firm Reminds Akorn, Inc. Investors of Important May 7 Deadline in Class Action ? AKRX [globenewswire.com]
NuVasive Announces First Quarter 2018 Financial Results [prnewswire.com]
Trevena Inc. and Jiangsu Nhwa Pharmaceutical Co. Ltd Announce License Agreement for Oliceridine in China [globenewswire.com]
WakeMed Selects Premier Inc. to Help Advance Journey Toward Value-based Healthcare | Business Wire [businesswire.com]
BioTime Presents Updated OpRegen® Clinical Trial Data at ARVO | Business Wire [businesswire.com]
Trevena and Pharmbio Korea Announce License and Commercialization Agreement for Oliceridine in South Korea [globenewswire.com]
Trevena to Report First Quarter 2018 Financial Results on May 3, 2018 [globenewswire.com]
2018 Hospital Merger and Acquisition Activity Continues Rapid Pace with 30 Announced Transactions [prnewswire.com]
2018 Hospital Merger and Acquisition Activity Continues Rapid Pace with 30 Announced Transactions in the First Quarter [prnewswire.com]
BioTime to Announce First Quarter 2018 Results on May 10, 2018 | Business Wire [businesswire.com]
New Research: Key Drivers of Growth for OFG, Oshkosh, Vishay Precision Group, Endocyte, BioCryst Pharmaceuticals, and Trevena ? Factors of Influence, Major Initiatives and Sustained Production [globenewswire.com]
Safeguard Scientifics Announces First Quarter 2018 Financial Results [prnewswire.com]
Global $13 Billion Spinal Surgery Devices Market Opportunity by 2022 - Analysis by Product, Method, Procedure, and End-User - ResearchAndMarkets.com | Business Wire [businesswire.com]
Biotech Stocks? Research Reports Released on TG Therapeutics, Trevena, Vanda Pharma, and Verastem [prnewswire.com]
Biotech Stocks' Research Reports Released on TG Therapeutics, Trevena, Vanda Pharma, and Verastem [prnewswire.com]
NuVasive Sponsors AANS 2018, Hosts Workshops And Presentations On Latest Innovations [prnewswire.com]
Lifshitz & Miller LLP Announces Investigation of Acadia Healthcare Company, Inc., Akorn, Inc., [prnewswire.com]
Lifshitz & Miller LLP Announces Investigation of Acadia Healthcare Company, Inc., Akorn, Inc., Blackhawk Network Holdings, Inc., Facebook, Inc., IZEA Inc., MuleSoft, Inc., Solid Biosciences Inc., and Tableau Software, Inc. [prnewswire.com]
Natus Confirms Receipt of Notice of Voce Capital?s Intent to Nominate Director Candidates to Replace 50% of the Natus Board [globenewswire.com]
The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Akorn, Inc. Shareholders and a Lead Plaintiff Deadline of May 7, 2018 (AKRX) [globenewswire.com]
Akorn Asks Delaware Court to Require Fresenius Kabi to Fulfill Its Obligations under Merger Agreement | Business Wire [businesswire.com]
Arcturus Therapeutics Founder Joseph Payne Dismisses Board?s Baseless Lawsuit as Desperate Entrenchment Tactic [globenewswire.com]
Akorn Issues Statement | Business Wire [businesswire.com]
Akorn Issues Statement [businesswire.com]
Disclaimer Red Acre Investments is not a registered investment advisor and the views and opinions offered herein do not constitute investment advice. Investors should always conduct their own due diligence before trading. You should assume that Red Acre is trading the securities mentioned in our Red Acre Insights, generally in accordance with the views we express, although our positions may change as news evolves. We do not undertake any obligation to update our views as market conditions evolve.
